title: ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.).
abstract: ZNF313 encoding a zinc-binding protein is located at chromosome 20q13.13, which exhibits a frequent genomic amplification in multiple human cancers. However, the biological function of ZNF313 remains largely undefined. Here we report that ZNF313 is an ubiquitin E3 ligase that has a critical role in the regulation of cell cycle progression, differentiation and senescence. In this study, ZNF313 is initially identified as a XIAP-associated factor 1 (XAF1)-interacting protein, which upregulates the stability and proapoptotic effect of XAF1. Intriguingly, we found that ZNF313 activates cell cycle progression and suppresses cellular senescence through the RING domain-mediated degradation of p21(WAF1). ZNF313 ubiquitinates p21(WAF1) and also destabilizes p27(KIP1) and p57(KIP2), three members of the CDK-interacting protein (CIP)/kinase inhibitor protein (KIP) family of cyclin-dependent kinase inhibitors, whereas it does not affect the stability of the inhibitor of CDK (INK4) family members, such as p16(INK4A) and p15(INK4B). ZNF313 expression is tightly controlled during the cell cycle and its elevation at the late G1 phase is crucial for the G1-to-S phase transition. ZNF313 is induced by mitogenic growth factors and its blockade profoundly delays cell cycle progression and accelerates p21(WAF1)-mediated senescence. Both replicative and stress-induced senescence are accompanied with ZNF313 reduction. ZNF313 is downregulated during cellular differentiation process in vitro and in vivo, while it is commonly upregulated in many types of cancer cells. ZNF313 shows both the nuclear and cytoplasmic localization in epithelial cells of normal tissues, but exhibits an intense cytoplasmic distribution in carcinoma cells of tumor tissues. Collectively, ZNF313 is a novel E3 ligase for p21(WAF1), whose alteration might be implicated in the pathogenesis of several human diseases, including cancers.
authors: School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
authors: J
authors: J
authors: Han
authors: Y-L
authors: YL
authors: Kim
authors: K-W
authors: KW
authors: Lee
authors: N-G
authors: NG
authors: Her
authors: T-K
authors: TK
authors: Ha
authors: S
authors: S
authors: Yoon
authors: S-I
authors: SI
authors: Jeong
authors: J-H
authors: JH
authors: Lee
authors: M-J
authors: MJ
authors: Kang
authors: M-G
authors: MG
authors: Lee
authors: B-K
authors: BK
authors: Ryu
authors: J-H
authors: JH
authors: Baik
authors: S-G
authors: SG
authors: Chi
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D051017:Apoptosis Regulatory Proteins; D002352:Carrier Proteins / Q000502:physiology*; D002453:Cell Cycle / Q000502:physiology; D059447:Cell Cycle Checkpoints / Q000502:physiology*; D002454:Cell Differentiation / Q000502:physiology; D002460:Cell Line; D045744:Cell Line, Tumor; D016922:Cellular Senescence / Q000502:physiology*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000502:physiology*; D044783:F-Box Proteins / Q000502:physiology; D064593:Heterografts; D006801:Humans; D066298:In Vitro Techniques; D047908:Intracellular Signaling Peptides and Proteins / Q000502:physiology; D008297:Male; D051379:Mice; D008819:Mice, Nude; D023421:Models, Animal; D009363:Neoplasm Proteins / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology*; D044767:Ubiquitin-Protein Ligases / Q000502:physiology*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; C493956:CDKN1A protein, human; D002352:Carrier Proteins; C493957:Cdkn1a protein, mouse; D050759:Cyclin-Dependent Kinase Inhibitor p21; D044783:F-Box Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009363:Neoplasm Proteins; D014157:Transcription Factors; C417551:XAF1 protein, human; C528956:XAF1 protein, mouse; C519134:Znf313 protein, mouse; C477146:RNF114 protein, human; D044767:Ubiquitin-Protein Ligases
references: J Biochem Mol Biol. 2007 Mar 31;40(2):270-6
references: 17394778
references: Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Mar;35(3):230-7
references: 12621547
references: Semin Cancer Biol. 2003 Feb;13(1):41-7
references: 12507555
references: Cell Cycle. 2011 Feb 1;10(3):457-68
references: 21248468
references: Nat Rev Cancer. 2001 Dec;1(3):222-31
references: 11902577
references: J Biol Chem. 2011 May 6;286(18):15641-51
references: 21454669
references: Biochem Biophys Res Commun. 2007 Mar 30;355(1):263-8
references: 17292858
references: Cancer Genet Cytogenet. 2006 Apr 15;166(2):157-62
references: 16631473
references: Nat Rev Cancer. 2008 Jun;8(6):438-49
references: 18500245
references: Mol Cell Biol. 1999 Mar;19(3):2109-17
references: 10022898
references: Cancer Res. 2003 Nov 1;63(21):7068-75
references: 14612497
references: Oncogene. 2006 Sep 21;25(42):5807-22
references: 16909101
references: Oncogene. 2008 Sep 25;27(43):5672-83
references: 18542055
references: Gastroenterology. 2007 Jun;132(7):2459-77
references: 17570219
references: Biochim Biophys Acta. 2009 Jul;1794(7):1010-6
references: 19285159
references: Nature. 2003 Jul 31;424(6948):516-23
references: 12872134
references: Hum Mol Genet. 2011 Aug 15;20(16):3129-37
references: 21571784
references: Cancer Res. 2003 Jun 15;63(12):3340-6
references: 12810668
references: BMC Cancer. 2007 Mar 21;7:52
references: 17376236
references: Cancer Res. 1995 Nov 15;55(22):5187-90
references: 7585571
references: PLoS One. 2012;7(4):e29824
references: 22539939
references: Cancer Lett. 2002 May 8;179(1):1-14
references: 11880176
references: Nat Cell Biol. 2001 Feb;3(2):128-33
references: 11175744
references: Annu Rev Biochem. 2009;78:435-75
references: 19489726
references: Hum Mol Genet. 2008 Jul 1;17(13):1938-45
references: 18364390
references: Genes Dev. 1999 Jun 15;13(12):1501-12
references: 10385618
references: Future Oncol. 2010 Oct;6(10):1643-52
references: 21062161
references: Int J Cancer. 1996 Nov 15;68(4):501-5
references: 8945622
references: Biochem J. 2008 Feb 15;410(1):101-11
references: 17990982
references: Cell. 2006 Aug 11;126(3):503-14
references: 16901784
references: Nat Genet. 2010 Nov;42(11):1000-4
references: 20953189
references: Int J Cancer. 2000 May 20;89(3):217-23
references: 10861496
references: Aging Cell. 2003 Jun;2(3):145-50
references: 12882406
references: Cancer. 2010 Mar 1;116(5):1252-63
references: 20082449
references: Mol Cell. 2007 Aug 3;27(3):462-73
references: 17679094
references: Oncogene. 1999 May 6;18(18):2789-97
references: 10362249
references: Hepatology. 2002 Jun;35(6):1476-84
references: 12029633
references: J Exp Med. 2008 Aug 4;205(8):1929-38
references: 18663127
references: Curr Biol. 1998 Mar 12;8(6):351-4
references: 9512419
references: Genes Dev. 2008 Sep 15;22(18):2507-19
references: 18794348
references: Mol Cell. 2005 Jan 21;17(2):237-49
references: 15664193
references: J Biol Chem. 2002 Aug 9;277(32):28504-11
references: 12029096
references: Cell Signal. 2007 Jul;19(7):1465-72
references: 17317101
references: Mol Carcinog. 2012 May;51(5):422-32
references: 21678496
references: Nat Rev Cancer. 2009 Jun;9(6):400-14
references: 19440234